US Stock MarketDetailed Quotes

BTAI BioXcel Therapeutics

Watchlist
  • 0.566
  • -0.004-0.74%
Close Oct 18 16:00 ET
  • 0.566
  • 0.0000.00%
Post 20:02 ET
23.05MMarket Cap-163P/E (TTM)

BioXcel Therapeutics Key Stats

Earnings

Revenue Breakdown

Financial Indicators

Income Statement

Balance Sheet

Cash Flow

BioXcel Therapeutics Earnings Estimates

Revenue

EPS

EBIT

Revenue is based on 5 analyst forecasts. Estimate data is from S&P, and actual data is from Income Statement

Currency: USD

Actual
Estimate
DatePeriodRevenue/EstimateEarnings Call
--2024/Q4-- / 1.810M--
--2024/Q3-- / 1.346M--
Aug 6, 20242024/Q21.104M / 1.100M--
May 9, 20242024/Q1582.000K / 632.600K--
Mar 12, 20242023/Q4376.000K / 741.290K--
DatePeriodRevenue/EstimateEarnings Call
--2024/Q4-- / 1.810M--
--2024/Q3-- / 1.346M--
Aug 6, 20242024/Q21.104M / 1.100M--
May 9, 20242024/Q1582.000K / 632.600K--
Mar 12, 20242023/Q4376.000K / 741.290K--

Unlock Free Earnings Estimates

BioXcel Therapeutics Earnings Reports

  • BioXcel Therapeutics | 10-Q: Q2 2024 Earnings Report

    Aug 6 09:08 ET

  • BioXcel Therapeutics | 10-Q: Q1 2024 Earnings Report

    May 9 09:10 ET

  • BioXcel Therapeutics | 10-K: FY2023 Annual Report

    Mar 22 16:43 ET

  • BioXcel Therapeutics | 10-Q: Q3 2023 Earnings Report

    Nov 14, 2023 08:15 ET

    • Read more

    Analysis

    Analyst Rating

    Updated: Oct 20, 2024

    Buy

    • Buy

      33.33%

    • Hold

      66.67%

    • Sell

      0.00%

    Price Target

    No Data

    Heat List
    US
    Overall
    Symbol
    Latest Price
    % Chg

    No Data